Veragene – NIPT
VERAgene NIPT is the first comprehensive non-invasive prenatal test (NIPT) that can simultaneously screen for common aneuploidies, clinically important microdeletions and a panel of 100 monogenic (single gene) conditions
- Down syndrome (Trisomy 21)
- Edwards syndrome (Trisomy 18)
- Patau syndrome (Trisomy 13)
SEX CHROMOSOME ANEUPLOIDIES:
- Turner syndrome (Monosomy X)
- Triple X Syndrome (Trisomy X)
- Klinefelter syndrome (XXY)
- Jacobs syndrome (XYY)
- XXYY syndrome
And MONOGENIC DISEASES – Such as Beta Thalassemia, Cystic Fibrosis, Sickle Cell Disease
- Available for single, twin and IVF pregnancies
- Available from 10 weeks of pregnancy
- 2 x 10ml Blood samples from the expectant mother
- 1 x Buccal cheek swab from Father
- Results within 7 days from arrival of the samples in the laboratory
If using a mobile device – please continue scrolling to see full product information
WHAT IS VERAGENE NIPT?
VERAGENE is the first comprehensive non-invasive prenatal test (NIPT) that can simultaneously screen for common aneuploidies, clinically important microdeletions and a panel of 100 monogenic (single gene) conditions such as; Beta Thalassemia, Cystic Fibrosis, Sickle Cell Disease etc.
The diseases screened by VERAGENE are often severe with significant impact on the quality of life.
VERAGENE targets 500 mutations to screen for 50 monogenic disorders.
By combining detection of aneuploidies and microdeletions with the screening of monogenic disorders, VERAGENE provides a comprehensive picture of the pregnancy using a single test.
HOW DOES VERAGENE WORK?
VERAGENE needs 2 x 10ml maternal blood sample*, and a buccal cheek swab sample from the biological father. The blood draw will need to be carried out by your Midwife, GP or Private hospital – there may be a small charge for this.
*If you live local to one of our boutiques, you can buy your test online and opt for a complimentary blood draw from our Manchester and Lancashire based boutiques. PLUS a FREE reassurance scan worth £45!
The maternal blood contains cell-free DNA (cfDNA) from both the mother and the fetus.
This cfDNA is isolated and analysed along with the father’s DNA sample for any potential genetic mutations using next generation sequencing.
Sophisticated bioinformatics algorithms are then used to compute the risk of the fetus having a monogenic disease.
HIGH READ-DEPTH These fragments are then counted several hundreds of times using NGS to achieve very high statistical accuracy and precision
The results are sent to My Baby Company who communicates them to the parents within 7 working days of the sample arriving at the laboratory.
VERAGENE is a safe test for both the mother and the fetus because it is performed using a simple blood draw rather than an invasive procedure.
We always recommend that you discuss your results with your Healthcare Professional
Who is VERAGENE for:
All pregnant women regardless of age are at equal risk of the genetic conditions screened by VERAGENE. Although the occurrence of each disorder is relatively rare, the cumulative rate of these conditions (~1 to 600) is similar to that of Downs Syndrome, in younger women.
For screening of AUTOSOMAL ANEUPLOIDIES:
Down syndrome (Trisomy 21)
Edwards syndrome (Trisomy 18)
Patau syndrome (Trisomy 13)
Plus SEX CHROMOSOME ANEUPLOIDIES:
Turner syndrome (Monosomy X)
Triple X Syndrome (Trisomy X)
Klinefelter syndrome (XXY)
Jacobs syndrome (XYY)
And MONOGENIC DISEASES
Such as Beta Thalassemia, Cystic Fibrosis, Sickle Cell Disease etc
We always recommend that results are discussed with your Healthcare Professional
Please take the time to familiarise yourself with our NIPT FAQs before placing your order
Please click here to view Brochure
Please click here to view list of conditions